Pegylated interferon
Pegylated interferon (PEG-IFN) is a class of medication that includes three different drugs as of 2012:[1]
In these formulations, Polyethylene glycol (PEG) is added to make interferon last longer in the body.[3] They are used to treat both hepatitis B,[4] hepatitis C[1] and multiple sclerosis.[2]
Pegylated interferon is contraindicated in patients with hyperbilirubinaemia.[citation needed]
References
[edit]- 1 2 Jirillo, Emilio, ed. (2008). Hepatitis C virus disease : immunobiology and clinical applications ([Online-Ausg.] ed.). New York: Springer. p. 237. ISBN 978-0-387-71375-5.
- 1 2 Kieseier BC, Calabresi PA.; Calabresi (2012). "PEGylation of Interferon-β-1a: A Promising Strategy in Multiple Sclerosis". CNS Drugs. 26 (3): 205–14. doi:10.2165/11596970-000000000-00000. PMID 22201341. S2CID 34290702.
{{cite journal}}: CS1 maint: deprecated archival service (link) - ↑ Martin P (February 15, 2001). "Hepatology Focus: Update on Hepatitis C Treatment: Pegylated Interferon". medscape.
- ↑ Dancygier H, Allescher HD (2010). Clinical Hepatology. [S.l.]: Springer Berlin Heidelberg. p. 765. ISBN 978-3-642-04509-7.
 | This antiinfective drug article is a stub. You can help Wikipedia by adding missing information. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by adding missing information. |